M&T Bank
TARO

M&T Bank’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

M&T Bank’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,536
Closed -$363K – 1786
2016
Q1 		$363K Buy
2,536
+519
+26% +$73.7K ﹤0.01% 1186
2015
Q4 		$311K Buy
+2,017
New +$294K ﹤0.01% 1279

Other funds holding TARO

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

M&T Bank's TARO Position: Q2 2016 in Review

M&T Bank sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2016, closing a stake of 2,536 shares — an estimated $363K sold.

M&T Bank first reported a position in TARO in Q4 2015 and held it in 2 quarters. The position peaked at $363K in Q1 2016. 159 funds tracked by Wall St. Rank hold TARO as of Q2 2016.

  • M&T Bank reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2016 after selling out during the quarter.
  • M&T Bank sold 2,536 Taro Pharmaceutical Industries Ltd. shares in Q2 2016, an estimated $363K.
  • M&T Bank first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 2 quarters.
  • M&T Bank's Taro Pharmaceutical Industries Ltd. position peaked at $363K in Q1 2016.
  • 159 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2016.

Based on M&T Bank's 13F filing for Q2 2016, filed 4 Aug 2016.